+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

From
From
From
Drugs for Rheumatoid Arthritis: Global Markets to 2022 - Product Thumbnail Image

Drugs for Rheumatoid Arthritis: Global Markets to 2022

  • Report
  • March 2018
  • 182 Pages
  • Global
From
From
Anti-Epileptic Drugs: Global Markets to 2022 - Product Thumbnail Image

Anti-Epileptic Drugs: Global Markets to 2022

  • Report
  • March 2018
  • 161 Pages
  • Global
From
Loading Indicator